Company · Ownership research

Neumora Therapeutics, Inc. NMRA

CIK 0001885522

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 40 rows; the complete set is available through the API.

Insider filings on file run through Aug 21, 2026.

Insider purchases & sales

Purchased: $21.11M
Sold: $3.77M

Nov 1, 2023 – Aug 21, 2026
Available records · partial months are marked ·

202410 of 11 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Oct 18, 2024	Fust Matthew K Director	Sale10b5-1 footnote	$239.32K 14,049 shares sold	41.14% sold Direct holding	▾
Oct 17, 2024	Fust Matthew K Director	Sale10b5-1 footnote	$131.64K 7,739 shares sold	27.80% sold Direct holding	▾
Oct 10, 2024	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$124.60K 8,260 shares sold	2.56% sold Direct holding	▾
Oct 9, 2024	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$83.51K 5,563 shares sold	1.69% sold Direct holding	▾
Sep 18, 2024	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$129.09K 10,676 shares sold	3.15% sold Direct holding	▾
Sep 17, 2024	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$363.74K 30,788 shares sold	8.32% sold Direct holding	▾
Sep 12, 2024	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$376.66K 32,948 shares sold	8.18% sold Direct holding	▾
Aug 27, 2024	Pinto Joshua Chief Financial Officer	Sale10b5-1 footnote	$178.81K 15,693 shares sold	10.15% sold Indirect holding	▾
Aug 26, 2024	Pinto Joshua Chief Financial Officer	Sale10b5-1 footnote	$372.59K 31,642 shares sold	16.98% sold Indirect holding	▾
Aug 23, 2024	Pinto Joshua Chief Financial Officer	Sale10b5-1 footnote	$280.01K 24,169 shares sold	11.48% sold Indirect holding	▾

Showing 11 / 11 record groups in 2024. The complete set is available through the API.

Neumora Therapeutics, Inc. · NMRA

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 11 of 11 purchase / sale groups and 30 of 40 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"NMRA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.